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Aims: Despite continuous efforts in improving the selection process, the rate of
non-responders to cardiac resynchronization therapy (CRT) remains high. Recent studies
on intraventricular blood flow suggested that the alignment of hemodynamic forces
(HDFs) may be a reproducible biomarker of mechanical dyssynchrony. We aimed to
explore the relationship between pacing-induced realignment of HDFs and positive
response to CRT.
Methods and results: We retrospectively analyzed 38 patients from the CRT database
of our institution fulfilling the inclusion criteria for HDFs-related echocardiographic
assessment early pre and post CRT implantation, with available mid-term follow-up (≥ 6
months) evaluation. Standard echocardiographic and deformation parameters early pre
and post CRT implantation were integrated with the measurement of HFDs through novel
methods based on speckle-tracking analysis. At midterm follow-up 71% of patients
were classified as responders (reduction of Left Ventricular Systolic Volume Indexed
≥ 15%). Patients did not display significant changes between close evaluations pre and
post-implant in terms of ejection fraction and strain metrics. A significant reduction of
the ratio between the amplitudes of transversal and longitudinal force components was
found. The variation of this ratio strongly correlates (R2 =0.60) with Left Ventricular (LV)
end-systolic volume variation at mid-term follow up.
Conclusion: Pacing-induced realignment of HDFs is associated with CRT efficacy at
follow up. These preliminary results claim for dedicated prospective clinical studies testing
the potential impact of HDFs study for patient selection and pacing optimization in CRT.
Keywords: cardiac resynchronization therapy, deformation imaging, hemodynamic forces, intraventricular
pressure gradient, cardiac mechanics, speckle tracking echocardiography
INTRODUCTION
Cardiac resynchronization therapy (CRT) is an established strategy for patients with symptomatic
heart failure (HF), reduced systolic function and prolonged QRS duration, improving symptoms
and long-term survival (1–4). Nevertheless, the effect of CRT is not homogeneous ranging between
the complete recovery of LV function to absent or only trivial changes in LV geometry and
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contractility (5). Despite strong efforts in the identification of
the appropriate candidates to CRT, the understanding of the
pathophysiological basis underlining the response to CRT is
largely incomplete and the rate of non-responders remains high
(5). This observation emphasizes the need for further studies to
improve patient selection.
Electrocardiographic criteria are considered the most reliable
for eligibility to CRT. However, a heterogeneity of CRT
response is found even in carefully selected patients with
LBBB morphology and QRS duration >120ms. Therefore,
imaging markers of mechanical dyssynchrony were considered
as adjunctive criteria for patient selection; however, results were
still heterogeneous in wide QRS patients, and even negative in
narrow QRS ones (6).
Hemodynamic Forces (HDFs), or equivalently
intraventricular pressure gradients (IVPGs), are a relatively
novel imaging marker of LV function. HDFs drive blood motion
during both ventricular ejection and ventricular filling, and
are deeply interconnected with physiological vortex formation
inside the LV (7). Under normal conditions, LV HDFs present
a dominant longitudinal (base-apex) orientation (8–10). Recent
studies demonstrated that a reduction of the longitudinal
component with a relative increase of the transversal ones
represent a sensible marker of dyssynchrony (11–13) and a
preliminary echocardiographic study suggested that that the
CRT-induced restoration of the normal orientation of LV HDFs
is associated with LV reverse remodeling (14).
Therefore, in the present study we sought (A) to describe
the pattern of HDFs in reduced ejection fraction HF (HFrEF)
patients with wide QRS, (B) to assess early CRT-induced
changes in HDFs and (C) to assess the potential relationship
between CRT-induced changes in HDFs orientation and mid-
term clinical response.
METHODS
Patient Selection and Study Design
We retrospectively analyzed all patients with successful CRT
device implantation consecutively included in the CRT-Registry
of our Institution (an ongoing research database prospectively
including all patients undergoing CRT) from January 2008 to
December 2016. Follow-up ended on 31 June 2017. Indication
for CRT was symptomatic HF with LV ejection fraction (LVEF)
≤35% and QRS duration ≥120ms, despite optimal medical
therapy. The study received institutional review board approval,
and informed consent was obtained under the institutional
review board policies of the hospital administration. Ischemic
etiology of HF was considered in the presence of significant
CAD (stenosis >50% of a major coronary artery on coronary
angiography) and/or history of prior myocardial infarction
or revascularization.
According to institutional protocol the majority of patients
implanted underwent complete echocardiographic examination
prior and after CRT implantation. Inclusion criteria for
the present study were: (1) available complete transthoracic
echocardiographic examinations within a close time range of
2 months before and after CRT implantation; (2) available
complete transthoracic echocardiographic examination at mid-
term follow-up (∼ 6months). Patients with poor quality imaging,
in particular not allowing the complete tracking of endocardial
profile in 4-, 2-, and 3-chamber apical view along with optimal
LVOT and aortic valve visualization, or with insufficient frame
rate (<50Hz) for speckle tracking analysis, were excluded.
All the metrics of interest, in particular HDFs, were analyzed
retrospectively in the last echo within 2 months before CRT
implantation (PRE) and in the first echo within 2 months
after implant (POST). CRT-induced changes in main parameters
[LVEF, LV End Systolic and End Diastolic Volume Indexed
(LVESVI and LVEDVI), end-systolic Global Longitudinal Strain
(GLS), Standard Deviation of Time To Peak of Longitudinal
Strain (SDTTPLS)] and in HDFs, where compared between PRE
and POST, and subsequently correlated with LV volumetric
remodeling at follow up. LV remodeling at follow up was
defined, as previously described (15), by relative changes
in LV End Systolic Volume (LVESV) [(follow-up LVESV—
PRE LVESV)/PRE LVESV∗100)] and categorized as follows:
super-responders (SR) patients had a LVESV reduction ≥30%;
responders (R) had a LVESV reduction ranging between 29
and 15%, non-responders (NR) had a LVESV reduction ranging
between 14 and 0% and finally negative-responders (NegR) had
an increase in LVESV.
The HDFs-related metric which resulted significantly
correlated with LV remodeling at midterm follow up, was
finally selected for prediction test of patient’s responder status (
intended equivalently as a LV volume reduction ≥15% and/or
R/SR category) (see Statistical analysis for further details).
Device Implantation
CRT devices from major manufacturers (Biotronik, Guidant-
Boston Scientific, Medtronic, Livanova-Sorin, and St. Jude
Medical) were used. Unipolar or bipolar leads were implanted
in posterolateral or lateral veins when feasible. Ablation of
the atrioventricular node after the procedure was considered
for patients with an unsatisfactory proportion of ventricular
pacing (<95%).
Echocardiographic Analyses
Echocardiograms were recorded on digital media storage devices
at the echocardiographic core laboratory of our Institution
and analyzed oﬄine according to current international
guidelines (16).
The three apical echocardiographic recordings (4-, 2-, and 3-
chamber) were re-analyzed oﬄine by a prototype version, that
includes the evaluation of HDFs, of a commercially available
speckle tracking solution (2DCPA v.1.4; TomTec Imaging
Systems Gmbh, Unterschleissheim, Germany). The software
requires drawing the end-systolic (ES) endocardial borders and
tracks the endocardial border over the entire heartbeat; it then
allows correcting the end-diastolic (ED) border and propagates
the correction over the entire cycle to match the original ES
border. The ES and ED volumes are computed by the Simpson
method, the GLS is computed as by guidelines (17); then a
measure of mechanical synchrony is evaluated by the standard
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deviation among the 16 segments of the time to peak of
longitudinal strain segmental curves (SDTTPLS).
From the three endocardial borders estimated by speckle
tracking during the cardiac cycle the software also computes
the HDFs. The calculation procedure is described in detail in
Pedrizzetti et al. (18), which reports also the validation with
respect to 4D Flow MRI measurements. Briefly, the total HDF
vector, F(t), exchanged between blood and tissues at every instant
during the cardiac cycle is evaluated by the balance ofmomentum
inside the LV volume V(t)
F (t) =
∫
S(t)
ρvvndS+
∫
V(t)
ρ
∂v
∂t
dV ,
where S(t) is the surface bounding the volume, v is the
velocity vector and the subscript n indicates the outward
normal component. The first term in the right-hand side of
the previous formula represents the flux of momentum across
the instantaneous LV volume boundary. This is computed from
the velocity at the LV endocardium, given by speckle tracking,
and by the mean velocity across the mitral and aortic valves
that is evaluated by the LV volume rate divided by the valve
area. The second term, due to blood inertia, is obtained by
the rate of change of the average velocity inside the LV, which
can be reliably estimated through simple assumptions on the
global intraventricular fluid dynamic (18). The time profile of
the longitudinal component (Fz(t), apex-to-base) and of themain
transversal component (Fx(t), inferolateral-anteroseptal) are thus
obtained, and they are normalized with the instantaneous LV
volume, and the blood specific weight, to have a dimensionless
number not directly affected by the chamber size.
The global amplitude of the individual HDF components is
described in terms of the root mean square (RMS) value of the
corresponding time profile during the heartbeat period T
RMSz =
√
1
T
∫ T
0 F
2
z (t)dt, RMSx =
√
1
T
∫ T
0 F
2
x(t)dt.
The entity of the deviation of the HDF from the
longitudinal direction is estimated by the ratio of the
amplitudes: RMSx/RMSz.
Statistical Analysis
Summary statistics of clinical and instrumental variables were
expressed as the mean and standard deviation (SD), median
and interquartile range (IQR), or counts and percentage,
as appropriate.
The longitudinal evolution of the parameters under study
from PRE- to POST- CRT examination was assessed by the
two-tailed paired Student t-test or Wilcoxon test according to
Gaussian or Non Gaussian distribution, with significance level
taken as p< 0.05.
Mechanical echocardiographic variables, and their changes
from PRE- to POST-CRT were correlated (Pearson test) with
the relative changes in LVESV (1LVESV), where 1 indicated
the difference from PRE to mid-term follow-up, divided by
PRE LVESV.
Correlations were graded by the coefficient of determination
R2, with significance threshold, R2 > 0.4. A receiver operating
characteristic (ROC) curve analysis was performed to determine
the best cutoff value (according to Youden criterion) of
RMSx/RMSz PRE, RMSx/RMSz POST, and δ(RMSx/RMSz),
where δ indicated the change from PRE to POST, for
differentiating “all grade” responders (including both R and SR,
i.e., with LVESV reduction at midterm follow up ≥ 15%) and
“all grade” non-responders (NR and NegR, LVESV reduction at
midterm follow up< 15%).
The Prism Software (GraphPad) version 5 was used for
descriptive analyses, and the Statistical processing was performed
with MatLab (Natick, MA, USA; MatLab R2014a, ver. 8.3.0.532
with Statistics Toolbox R2014aR).
Reproducibility of HDFs Analysis
Inter-operator variability of HDFs quantification was evaluated
by repeating evaluation on the same images by a second operator,
blind to the previous results, on all 38 patients both on echo PRE
and POST CRT (76 triplane samples). This allowed to obtain
a power of 80% to identify an intraclass correlation coefficient
(ICC) of 0.70, under the null hypothesis of ICC equal to 0.50,
using an F test at a level of significance equal to 5% and intra-
operator ICC of 0.80 under the null hypothesis of 0.60. The
differences were described in terms of average with 95 confidence
interval; statistical comparison was also verified by a paired two-
tailed Student t-test with significance level assumed p = 0.05.
Bland—Altman analysis was also performed to verify the absence
of systematic bias.
RESULTS
Study Population Characteristics
Of the about 300 patients included in CRT registry in the
selected period, only 38 fulfilled inclusion criteria. Table 1
shows main clinical and echocardiographic characteristics of
the study population at PRE-CRT (median time 12 days before
implantation, IQR 6-46) and at midterm follow up (median
time 7.3 months after implantation, IQR 4-10.5). Basal QRS
duration was 166 ± 24ms, and LBBB morphology was present
in 97% of patients. Comprehensively, both LVEDV and LVESV
decreased at mid-term follow-up with a coherent improvement
in LVEF, with 71% of our patients classified as R or SR, whereas
the remaining 29% were classified NR or NegR, according to
the abovementioned classification. QRS duration, in parallel,
decreased at 156± 23 ms.
In Table 2 the main echocardiographic parameters assessed
at PRE-CRT examination were compared with POST-CRT
examination (median time 3 days post-implantation, IQR 2-9).
The LV volumes present a quantitatively small but statistically
significant (p < 0.001 for both) reduction from PRE to POST.
The other variables, LVEF, GLS, SDTTPLS and the amplitude
(RMS) of HDF force components did not present significant
changes; however, a small increase in GLS and in the value
of RMSz was noticed POST implant. Most importantly, the
ratio between transversal and longitudinal HDFs (RMSx/RMSz)
shows a significant reduction POST CRT (p = 0.011). This
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TABLE 1 | Population characteristics and main echocardiographic data at basal
and midterm follow up.
Population baseline characteristics Total (n = 38)
Age 64 (37–83)
Male(%) 28 (73%)
Ischemic etiology(%) 10 (26%)
LBBB (%) 37 (97%)
QRS duration (ms) 166 ± 24
AF (%) 9 (23%)
NYHA class III-IV(%) 16 (42%)
SBP (mmHg) 119 ±18
ACE inhibitors/ARBs therapy (%) 34 (89%)
Beta blocker therapy (%) 32 (84%)
MRA therapy (%) 20 (52%)
Loop diuretics (%) 37 (97%)
HF duration (months) 76 (35–136)
ECHOCARDIOGRAPHIC BASELINE (PRE) CHARACTERISTICS
LVEDVI (ml/m2) 118 (97–164)
LVESVI (ml/m2) 92 (73–127)
LVEF (%) 22 ± 6
MR ≥ 2+ (%) 27 (71%)
POPULATION CHARACTERISTICS AT MIDTERM FOLLOW UP
Time to Echo at follow up (months) 7.3 (4–10.5)
LVEDVI (ml/m2) 96 (76–124)*
LVESVI (ml/m2) 67 (48–95) #
LVEF (%) 33 ± 11§
NYHA class III-IV(%) 8 (21%)
MR ≥ 2+ (%) 21 (55%)
QRS duration (ms) 156 ± 23
Ventricular Pacing (%) 97 ± 3
SR/R/NR/NegR 17 (45%) /10 (26%) /5 (13%) /6
(16%)
Values are expressed as the mean ± SD or median with interquartile range, and as a
percentage (%).
LVEDVI, left ventricular end-diastolic volume indexed; LVESVI, left ventricular end-systolic
volume indexed; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; SBP,
systolic blood pressure; GLS, global longitudinal strain; *p < 0,0001 with LVEDVI basal;
#p < 0,0001 with LVESVI basal, §p < 0,0001 with LVEF basal, SR, Super responders; R,
Responders; NR, Non responders; NegR, Negative responders.
ratio was selected for further evaluation: with respect to the
evaluation of single RMSz or RMSx taken separately, their
combined evaluation expressed by this ratio seems to offer amore
accurate representation of the degree of alignment of LV IVPGs
distribution in disease state. Figure 1 highlights the role of this
parameter in the study design.
Correlations With Midterm Follow Up
In order to assess the value of an alignment of HDFs, expressed
by RMSx/RMSz, as a potential predictor of responder status at
midterm follow up, a correlation study between δ(RMSx/RMSz)
and the variation of LVESV at midterm follow up (1LVEVS)
was performed. This evaluation was compared with respect
to the early changes (δ) in LVEF (as a main indicator of
LV systolic function), LVESV (to differentiate midterm follow
TABLE 2 | Comparison of early changes in main echocardiographic parameters
after CRT implant.
Last echo
PRE CRT
Early first
echo
POST CRT
p-value
Time from last echo to CRT (days) 12 (6–46) — —
Time from CRT to echo (days) — 3 (2–9) —
LVEDVI (ml/m2) 118 (97–164) 112 (83–143) p = 0.0006
LVESVI (ml/m2) 92 (73–127) 80 (65–115) p = 0.0005
LVEF (%) 22 ± 6 22 ± 8 NS
GLS −5.8 ± 2.5 −6.4 ± 3.0 NS
SDTTPLS 14.2 ± 5.9 14.0 ± 6.5 NS
RMSz (Apex-Base) 0.058 ± 0.040 0.064 ± 0.033 NS
RMSx (iLat-aSept) 0.024 ± 0.013 0.023 ± 0.010 NS
RMSx/RMSz 0.46 ± 0.18 0.39 ± 0.12 p = 0.0107
Values are expressed as the mean ± SD or median with interquartile (IQR) range.
LVEDVI, left ventricular end-diastolic volume indexed; LVESVI, left ventricular end-systolic
volume indexed; LVEF, left ventricular ejection fraction; GLS, global longitudinal strain;
SDTTPLS, standard deviation time to peak of longitudinal strain; RMSz, root mean
square of longitudinal hemodynamic force; RMSx, root mean square of transversal
hemodynamic force.
up with respect to early changes), and in SDTTPLS (as an
indicator of mechanical synchrony). Figure 2 shows the resulting
correlation graphs and relative coefficients: in our population
δ(RMSx/RMSz) shows the best correlation (R2 = 0.60) with the
variation of LVESV at mid-term follow-up (1LVESV). The early
change in LVEF and in SDTTPLS did not display any correlation
with follow up; a small non-significant correlation (R2 = 0.30)
was found between the early (δ) and the midterm follow up (1)
variation in LVESV (summarized in Table 3).
The early decrease in the RMSx/RMSz ratio corresponds to
an improved alignment of HDFs after CRT, which represents a
measure of the extent of restored physiological LV IVPGs: this
correlates with the reduction of LVESV found at a later time.
In this perspective, the significance of early change in this ratio
was tested with ROC analysis to evaluate if it is predictive of the
response status at midterm follow up.
As shown in Figure 3C, at ROC analysis the δRMSx/RMSz
showed a good accuracy for the prediction of all grade responder
status (R/SR) vs. NR/NegR at mid-term follow up (area under
the curve (AUC)= 0.891; 95% Confidence Interval (CI) 0.787–
0.995, p< 0.001). The optimal cut-off of δRMSx/RMSz identified
at ROC analysis was −15.1% with a sensitivity and a specificity
of 73% and 92%, respectively, for R/SR prediction. Neither
the absolute value of this ratio evaluated separately at PRE
(Figure 3A, AUC: 0.728, 95% CI 0.557–0.898, p = 0,026) nor
POST (Figure 3B, AUC 0.569, 95% CI 0.382–0.784, p=0,5)
showed similar predictive accuracy.
Reproducibility of HDFs Analysis
The mean of inter-operator difference for the ratio RMSx/RMSz
was −0.006 (95% confidence interval −0.02416–0.01206), with
p = 0.51 in the paired Student t-test. Intraclass correlation
coefficient (ICC) resulted equal to 0.91 (95% CI: 0.86–0.94).
The Bland-Altman analysis, reported in Figure 4, evidences a
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FIGURE 1 | Representation of study design: (C) patient’s categorization according to different values of RMSx/RMSz PRE CRT implant, and their variation POST CRT,
which resulted representative of responder status at follow up. Polar representation of the distribution of hemodynamic forces in a Super Responder (SR) patient pre
(A) and post (D), and in a Negative Responder (NegR) pre (B) and post (E) CRT implant.
FIGURE 2 | Different Correlations between early changes (expressed by “δ”: from echo PRE CRT implant to echo POST) of selected echocardiographic parameters
[(A) LVEF, (B) LVESV, (C) SDTTPLS, (D) RMSx/RMSz], with relative long term variation of LVESV at midterm follow up(1LVESV %).
TABLE 3 | Correlations between early changes (“δ”, from PRE to POST implant) of
main echocardiographic parameters and difference of LVESV from PRE to
follow-up (1LVESV).
R²
δLVEF (%) 0,07
δSDTTPLS 0,05
δLVESV 0,31
δRMSx/RMSz 0,60
negligible bias equal to −0.006 and 95% limits of agreement
in the interval from −0.161 to 0.149. The reproducibility was
statistically satisfactory.
DISCUSSION
In this pilot, hypotheses-generating retrospective study we
demonstrated the feasibility and the potential utility of the
sequential echocardiographic assessment of HDFs in CRT
recipients as an early marker of resynchronization efficacy at
follow-up. To the best of our knowledge, this is the first paper
assessing this technique in this setting, and we found it capable
to provide us valuable new information about LV function at
baseline and early after therapy. In our scenario, this information
contributes to a better categorization of patients in terms both of
therapy’s response and efficacy at follow up.
The main objective of LV function is that of creating flow
that, by the law of physics, can develop only in consequence
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FIGURE 3 | Receiver Operating Characteristic Analysis (ROC) on the all grade Responder Status (R/RS, vs. NR/NegR) at midterm follow, for the hemodynamic force
ratio: (A) RMSx/RMSz measured PRE implant, (B) RMSx/RMSz measured POST implant, and (C) early variation δ(RMSx/RMSz) from PRE implant to POST implant.
The presence of poor alignment of forces before implant has a mild predictive value for the responder status (A); this does not apply for the value measured after
implant (B). Moreover, the improvement of alignment induced by biventricular pacing shows the best predictive value of the eventual responder status at follow up.
FIGURE 4 | Bland-Altman analysis of inter-operator variability in the triplane measurement of RMSx/RMSz. The analysis performed on all patients in both pre- and
post-implant recordings (76 cases), shows the absence of a systematic bias.
of an intraventricular pressure gradient (IVPG). Normal IVPGs
are aligned along the base-apex direction in compliance with
the ejection-filling blood motion that occurs from base to apex
during systole and vice versa during diastole (8, 9). This natural
function means, for example during systole, that the contraction
of a region of the LV wall combines with that of facing regions
to create a synergistic thrust from the blood pool toward the
outflow tract. When this does not occur, as it is in presence
of intraventricular dyssynchrony due to LBBB, the contraction
of a wall creates a transversal force that overloads the facing
regions through the column of fluid (an incompressible medium)
between them instead of creating and ejective force. The presence
of transversal IVPGs, as it is found in patients with dilated
cardiomyopathy (10), thus corresponds to a sub-optimal LV
function where the myocardial effort is not functional to ejection
and it is spent to stress other regions of the myocardium itself.
Recent 4DFlow studies demonstrated that the increase of the
transversal component of HDF with respect to the longitudinal
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one represents a sensible quantitative marker for the presence
of mechanical dyssynchrony (11, 12). Therefore, restoring the
natural longitudinal orientation of HDFs corresponds to an
improvement of LV synchrony and it is suggested that it may
correlate with the favorable response to CRT (14).
This paper applies for the first time a novel method for
the estimation of HDFs by regular B-mode images in patients
undergoing CRT. This pilot observational study shows, in line
with above mentioned preliminary observations (11, 12), that
patients with severe LV dysfunction and wide QRS complex
show reduced longitudinal HDFs and consequently a relatively
increased ratio of transversal/longitudinal HDFs at baseline.
A high value of this ratio at baseline witnesses the presence
of mechanical dyssynchrony that, in this cohort, is by itself
potentially predictive of responder status at midterm follow
up (Figure 3A). Moreover, the relative reduction of this ratio
induced by pacing is found to have the best predictive accuracy
for the efficacy of this treatment at follow up. A growing amount
of evidences progressively discovered the importance of the study
of myocardial blood flow where vortex formation and HDFs are
considered a powerful source of information about LV function
(7, 19–21). Despite these suggestions, clinical results are still
limited and the applicability of parameters associated to blood
dynamics is still uncertain. This is also due to the complexity
of techniques for quantifying flow properties in clinical practice.
The present results provide an initial evidence for the clinical
applicability of a relatively simple method for estimating HDFs
parameters (18).
The main net outcome of CRT is ascribed to the responder
status at follow up. In the complex world of CRT, many
measures of mechanical synchrony have been suggested in
order to identify the criteria with highest predictive value (22–
24). However, results have been often controversial and non-
conclusive (25, 26). One reason could be that synchrony is
commonly translated in terms of a requirement of simultaneity
for the motion of the LV walls. Simultaneity does not always
correspond to an optimal, synergistic dynamics, because the
natural LV contraction can present small timing differences that
ensure the development of longitudinal IVPGs for the rotatory
blood motion due to the vortex. The analysis of HDFs properties
may provide more appropriate parameters that correspond to the
net result of the many factors concurring to a synchronous LV
contraction. In the clinical setting, compared to other techniques
of HDFs assessment [e.g., with MRI or echo particle image
velocity (Echo-PIV)], the one tested here seems to offer a more
easily achievable, reproducible, time and cost saving resource.
Furthermore, if confirmed prospectively, the evaluation of HFDs
modifications during and early after CRT implantation may
be helpful both in eventual optimization of pacing parameters,
aimed to obtain a satisfactory reduction of RMSx/RMSz , and
in follow up scheduling (a closer visit may be recommended in
those patients in which this reduction is not obtained despite
pacing optimization). Finally, as previously mentioned, it has to
be underlined that the absolute value of this ratio shows per se
at baseline (PRE) the potential to predict a higher probability of
favorable response to CRT: in respect to the current claim for
more accurate selection criteria in CRT recipients (5), this aspect
deserve further evaluation in future prospective studies.
Study Limitations
The present study was performed retrospectively on a small
sample of patients. Thus, our preliminary results should be
considered as proof of concept and hypotheses generating,
future larger prospectives investigations are required to explore
more extensively the applicability and the advantages of this
methodology in candidates to CRT. The time intervals between
PRE and POST echocardiographic evaluations were slightly
different among patients. However, in our opinion the limit
of 2 months avoided that the progression of the underlying
disease, rather than the net effect of biventricular pacing, might
have influenced HDFs. With respect to the optimization of
the recording protocol, the echocardiographic exams PRE and
POST implant were performed without considering the need of
a comparative assessment, thus a variability may also be partly
imputable to small changes in the acquisition practice including
different operators.
This study was aimed to provide an initial evaluation of an
approach based on HDFs for the prediction of response to CRT.
This preliminary work was required for verifying whether this
approach could deserve the design of a prospective clinical study
in the same subject.
CONCLUSIONS
This pilot observational study demonstrated that the realignment
of LV HDFs induced by biventricular pacing, assessed through
a new echocardiographic technique early after implantation,
correlates with LV reverse remodeling at follow-up in HFrEF
patients treated with CRT. These results should encourage
the design of a larger prospective clinical study to verify the
potential of systematic HDFs assessment in selecting the optimal
candidates to CRT and in guiding pacing optimization.
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